文献速递产科母胎医学

构建子痫前期决定因素概念框架:生物标志物的分层系统评价

Towards the Development of a Conceptual Framework of the Determinants of Pre-Eclampsia: A Hierarchical Systematic Review of Biomarkers.
PubMed 文献 · BJOG · 2025-05-08

该分层系统评价检索至2024年4月的多个数据库,纳入报告子痫前期相关生物标志物的综述与样本量>100的队列研究,采用GRADE评估证据质量。共识别40个生物标志物决定因素,其中18个具有明确或可能的关联,血管内皮生长因子等5个标志物基于高质量证据具有明确关联。

要点

  • 共识别40个子痫前期生物标志物决定因素,18个具有明确或可能关联。
  • 血管内皮生长因子、人绒毛膜促性腺激素等5个标志物基于高质量证据具有明确关联。
  • 生物标志物(含超声标志物)的加入可优化子痫前期预测并实现个体化风险分层。

核心结论

  • 与子痫前期发生相关的生物标志物突显了该综合征的多因素病因。
  • 加入生物标志物(包括超声标志物)将优化子痫前期的预测并实现个体化风险分层。

研究设计与样本

  • 分层系统文献综述,检索Medline、Embase、Health Technology Assessments、Database of Abstracts of Reviews of Effects、Cochrane Library,检索截止至2024年4月。
  • 纳入报告子痫前期相关生物标志物的综述和样本量>100名参与者的队列研究。
  • 证据优先顺序为伞状综述、系统评价、观察性研究,使用GRADE评估关联强度和证据质量。

主要发现

  • 生物标志物领域共包含40个子痫前期个体决定因素。
  • 其中18个生物标志物基于中等至强质量证据具有明确或可能的关联,涉及血管生成失衡、胎儿-胎盘单位功能、炎症和免疫标志物以及生理标志物。
  • 血管内皮生长因子、人绒毛膜促性腺激素、抑制素-A、母体血清胎盘蛋白-13和干扰素-γ基于高质量证据具有明确关联。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pre-eclampsia is a leading cause of maternal and perinatal morbidity and mortality. There are several determinants of individual pregnant women's risk of developing pre-eclampsia, including biomarkers and ultrasound markers. OBJECTIVE: A conceptual framework to collate and summarise the extensive body of literature on biomarkers (including ultrasound markers) associated with pre-eclampsia, through a hierarchical systematic literature review. SEARCH STRATEGY: Medline, Embase, Health Technology Assessments, Database of Abstracts of Reviews of Effects, Cochrane Library were searched until April 2024. SELECTION CRITERIA: Reviews and cohort studies (> 100 participants) reporting biomarkers associated with pre-eclampsia were included. DATA COLLECTION AND ANALYSIS: Studies were screened by title, then abstract and full text. Evidence was prioritised from umbrella reviews, followed by systematic reviews and then observational studies. Associations were assessed for strength of association and quality of evidence using GRADE. MAIN RESULTS: The biomarker domain included 40 individual determinants of pre-eclampsia. Of these, there were 18 biomarkers with definite or probable associations based on moderate-strong quality evidence across markers of angiogenic imbalance, fetal-placental unit function, inflammatory and immune markers, and physiological markers. Vascular endothelial growth factor, human chorionic gonadotropin, inhibin-A, maternal serum placental protein-13, and interferon-gamma had definite associations based on high-quality evidence. CONCLUSION: Biomarkers associated with the development of pre-eclampsia highlight the multi-factorial aetiology of the syndrome. The addition of biomarkers, including ultrasound, will optimise the prediction of pre-eclampsia and enable individualised risk stratification.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Elawad T, Mistry HD, Kinshella MW, et al. Towards the Development of a Conceptual Framework of the Determinants of Pre-Eclampsia: A Hierarchical Systematic Review of Biomarkers. BJOG. 2025. PMID: 40344291. doi:10.1111/1471-0528.18194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。